Blogs, insights, guides and videos on India's unlisted market — all in one place.
Lotte India Corporation Limited has announced its annual report for the financial year ended March 31, 2022. The company witnessed rapid growth in its sales and gross revenue. However, due to high expenses, the profit of the company decreased significantly. For FY22, the gross income of the company increased 15%, to Rs. 458 crore as against Rs. 397 crore in the previous financial year. The total expenses of the company increased 19%, to Rs. 457 crore against Rs. 385 crore in the previous financial year. The PBT of the company witnessed a massive drop of 93%, to Rs. 90 lacs compared to Rs. 12 crore in the previous financial year. The net profit of the company increased 15%, to Rs. 11 crore as against Rs. 10 crore in the previous financial year. The basis earning per share of the company was Rs. 10.59 compared to Rs. 9.25 in FY21. The total assets of the company was Rs. 706 crore as against Rs. 710 crore in the previous financial year. The equity and liabilities of the company stood at Rs. 706 crore as against Rs. 710 crore. For FY22, the cash flow from operating activities of the company was Rs. 44 crore as against Rs. 54 crore in the previous financial year. The cash outflow from investing activities was Rs. 1 crore as against Rs. (30) crore in FY21. The net cash outflow from financial activities stood at Rs. (55) crore as against Rs. (36) crore in previous financial year. Net cash and cash equivalents decreased in FY22 was (6) crore as against Rs. (5) crore in FY21. Lotte India Corporation Limited is engaged in the business of manufacturing and marketing of confectionery products. It is the subsidiary of Lotte Confectionery Company Limited, South Korea, which is one of the leading manufacturers of confectionery products. The Company has three manufacturing plants in India and manufactures/ distributes a wide range of confectionery products including Chocopie, Coffy Bite, Lacto King, Frutopie, Caramilk, Coconut Punch and Spout Gums.
Rydak Syndicate Limited has announced its annual report for the financial year ended March 31, 2022. As per the annual report, the gross revenue of the company increased by 14%, to Rs. 147 crore, as against Rs. 129 crore in the previous financial year. During the financial year ended March 31, 2022, the total expenses increased 8%, to Rs. 122 crore as against Rs. 114 crore in FY21. The company has reported a massive increase in its PBT compared to the previous financial year. For FY22, the PBT of the company increased 66%, to Rs. 24 crore, compared to Rs. 15 crore for the previous financial year. The net profit for FY22 increased 57%, to Rs. 22 crore, as against Rs. 15 crore in the previous financial year. The total assets of the company increased by 10%, to Rs. 111 crore as against Rs. 101 crore in FY21. The total equity and liabilities of the company also increased by 10%, to Rs. 111 crore, compared to Rs. 101 crore in the previous financial year. For FY22, the net cash flow generated from operating activities was Rs. 24 compared to Rs. 21 crore in the previous financial year. During FY22, the net cash used in investing activities stood at Rs. 6 crore, compared to Rs. 8 crore in FY21. Net cash used in financial activities was Rs. 9 crore as against Rs. 13 crore in the previous financial year. The net increase in cash and cash equivalents for FY22 was Rs. 8 crore compared to Rs. ( 0.0040) crore in FY22. Rydak Syndicate Limited is a company incorporated under the Companies Act, 2013. The company’s shares are listed on the Calcutta Stock Exchange. The company is involved in harvesting, manufacturing, and selling of tea business. The company has also commenced operations commercially as a Tea Tourism operation in Dooars Region in the name of Baradighi –The Bungalow by converting one of its heritage Bungalows into a commercial property.
Elcid Investment Limited has announced its annual report for the financial year ended March 31, 2022. As per the report, in FY22, the total revenue of the company increased 25%, to Rs. 134 crore as against Rs. 107 crore in the previous financial year. In FY22, the total expenses of the company have also increased 206%, to Rs. 4 crore compared to Rs. 1 crore in the previous financial year. The PBT of the company has reported an increase of 23%, to Rs. 131 crore compared to Rs 106 crore in FY21. The net profit of the company has increased 23%, to Rs. 100 crore as against Rs. 81 crore in the previous financial year. The EPS, basic and diluted, of the company also increased to Rs. 5,001.94, up by 23% as against Rs. 4,052.46 in the previous financial year. The directors of the company recommended the final dividend of Rs. 15 pet equity shares for the financial year ended March 31, 2022. During the fiscal year that concluded on March 31, 2022, the ELCID had investments of Rs. 9164 Cr. According to their share capital, they have 2,000,00 outstanding shares. Therefore, if you divide this investment by the number of shares, the per-share value of ELCID unlisted share is Rs.4,80,000, and ELCID's delisting offer price was Rs. 1,62,000 and the same was rejected by investors as it was very low. The net cash flow from operating activities of the company was Rs. 61 crore as against Rs. 14 crore in the previous financial year and the net cash flow from investing activities was Rs. -68 crore compared to Rs. -11 crore in the previous financial year while the net cash flow from financial activities stood at Rs. -29 lakhs for FY22 which is the same as against the previous financial year. The net cash and cash equivalents for the financial year ended March 31, 2022 stood at Rs. 1 crore as against Rs. 8 crore in the previous financial year. In FY22, The total investment value of the company increased to Rs. 13159 crore as against Rs.10830 crore in the previous financial year. Elcid Investments Limited is a non-banking financial Company (NBFC) registered with the Reserve Bank of India (RBI) under the category of investment Company. The Company's activities primarily consist of investing in listed and unlisted equity shares, debt instruments of companies and in mutual funds.
GKN Driveline India Limited has announced its annual report for the financial year ended March 31, 2022. As per the annual report, the gross revenue of the company increased 25%, to Rs. 860 crore as against Rs. 689 crore in the previous financial year. The net expenses of the company have also increased to Rs. 771 crore compared to Rs. 618 crore for the financial year FY21. For FY22, the PBT of the company has reported an increase of 20%, to Rs. 89 crore as against Rs. 71 crore in the previous financial year. The PAT of the company increased 16%, to Rs. 65 crore as against Rs. 56 crore in the previous financial year. The EPS for the financial year F22 stood at Rs. 51.40 per equity shares. The NPM for the financial year F22 was 7.5%. For FY22, the net cash flow generated from operating activities was Rs. 131 crore, 87% up compared to the previous financial year which was Rs. 70 crore. In F22, Cash and Cash Equivalents increased 50%, to Rs. 151 crore as against Rs. 101 crore. The Board of Directors of the Company have declared an interim dividend of INR 62 per equity share of face value of INR 10 each for the year 2021-22. The passenger vehicle sales grew 13.2% to 30,69,499 units in FY21-22 compared to 27,11,457 units in FY 2020-21 sales. Sales of passenger cars stood at 14,67,056 units, utility vehicles at 14,89,178.The UV segment crossed 1.4 million sales for the first time, and it is the only segment registering 40% growth contributed by new launches and strengthening of new players in auto manufacturing. The exports showed an increasing trend mainly due to opening of the international market after covid restrictions. The Company maintains interaction with GKN Group internationally which ultimately helps the company to grow the business. Under the technical collaboration, the company continuously imports advanced technology from GKN group. To drive functional excellence in marketing, human resource, application engineering, supply management and information technology, among others, the Company is continuously receiving support and guidance from GKN Group.
Resins and Plastic Limited has announced its annual report for the financial year ended March 31, 2022. Despite the Covid-19 outbreak, the company outperformed in terms of sales and revenue. The total sales of the company increased by 47%. For FY22, the total income of the company was Rs. 215 crore, as against Rs. 149 crore in the previous financial year. However, due to the surge in the cost of raw materials, the total expenses of the company also increased 50%, to Rs. 199 crore, compared to Rs. 133 crore for the financial year 2021. In FY22, the PBT of the company remained almost the same compared to the previous financial year which stood at Rs. 15 crore. The PAT of the company was Rs. 11 crore, which is almost the same compared to the previous financial year. The net profit of the company was Rs. 11 crore for the financial year FY22. EPS basic and diluted of the company for F22 was Rs. 28. For the financial year ended March 31, 2022, the NPM of the company stood at 5.11%. The non-current liabilities of the company were Rs. 1 crore, while the current liabilities stood at 109 crore. The non-current assets of the company was Rs. 14 crore and the current assets was Rs. 109 crore. The net cash flow generated from operating activities was Rs. 2 crore while EBITDA was Rs. 16 crore. That means only 12% of EBITDA is getting converted into cash which is very low. This should be above 70% for efficient companies. The cash and cash equivalents at the end of the year was Rs. 67 lakhs. The directors of the company recommended the dividend of 6.00/- per equity share for the financial year ended March 31, 2022. The Synthetic Resins manufactured by the company primarily caters to the Industrial Coatings, Printing Inks, Adhesives and Construction Chemical Industry. Talking about the Company’s customer base, it largely comprises small and medium scale companies and some large Corporates. During the financial year 2021-22, raw material prices witnessed high volatility throughout the year due to COVID-19 and its impact on imports. Restriction on imports from certain countries due to geopolitical reasons, short supply of some key raw materials, Increase in freight cost, Foreign exchange fluctuations, the Ukraine war followed by sky rocketing fuel prices led to 15-20% increase in raw material pricing thereby considerably diminishing market sentiments. Despite all these odds the Company was able to keep the supply pipeline at normal level. This year, the Resin and Plastic unlisted share management has placed special focus on upgradation of infrastructure in all three manufacturing units with a view to improving productivity, cost effectiveness and quality. The Taloja Plant, which completed 50 years of manufacturing in December 2021, underwent major upgrading in terms of replacement of old and low efficient equipment, office renovation, new roads, new storm water drainage system, upgradation of main and material gate, etc. The R & D center was also upgraded. Renovation of the lab, purchase of new equipment to assist new age technology and development of products occurred this year. The company is also focusing on diminishing wastages and improving efficiency. During the year Resin and Plastic manufacturing unit i.e. Ankleshwar Unit received Environmental clearance for enhancing its capacity to make larger volumes which will help to meet Customers requirements more proactively. A notable achievement during the year has been the successful Company Wide implementation of the Integration Management System (IMS). The company has now been recommended for ISO Certification.
<h3>Paytm Share Price Journey</h3> <h4>About Paytm Share Price Jouney</h4> Established in 2010 under One97 Commutation Private Limited, Paytm is a digital payment and financial services company based in Noida founded by Vijay Shekhar Sharma. It also offers e-commerce services; ticket booking, hotel booking, bill payment, insurance, investment, banking, etc. Paytm was the very first company to provide wallet facilities in the country. Inspired by his visit to China, Vijay Shekhar Sharma started Paytm Wallet in 2010. The company got astonishing popularity and growth during demonetization in 2016. The Paytm app has 100+ million downloads on the Google Play Store. With the introduction of new competitors such as Phonepe, Google Pay, and Bharat Pe, the company is facing many challenges. In March 2022, the RBI barred Paytm from acquiring new customers, citing "material supervisory concerns." This resulted in a huge setback for the company in terms of business. <img class="wp-image-25002 aligncenter" src="https://unlistedzone.com/storage/knowledge-logo/Paytm-Share-Price.png" alt="Paytm Share Price" width="463" height="302" /> <h4>Paytm Share price movement in the unlisted market ?</h4> Despite the fact that the company was losing money, the Paytm shares were always in high demand in the unlisted market. In the unlisted market, the Paytm share price ranged from Rs. 8000 to Rs. 12,000 per equity share from 2018 to March 2021. The company's valuation ranged from $6.4 billion to $9.6 billion at the time. And if you look at Paytm's most recent fundraising round, which Softbank completed in 2019, its valuation was $16 billion. <a href="https://en.wikipedia.org/wiki/Paytm"><em><span style="font-size: 8pt;">(Paytm)</span></em></a> Therefore, compared to the previous valuation, it was considerably discounted on the unlisted market. When the business filed for an initial public offering (IPO) in June 2021, the market was booming and everyone anticipated that Paytm would be valued at $25 billion, or Rs.31,000 per share. Everyone then began purchasing on the unlisted market. The price increased on the unlisted market from Rs. 12,000 to Rs. 35,000. The split was then announced at a 10:1 ratio sometime between September and October 21. As a result, the price dropped from 35000 to 3500, and the number of shares increased from 1 to 10. One month prior to the IPO's launch, on October 21, FIIs began to pull their money out of the market, which caused the market to crash. The Paytm share price was therefore valued at $17 billion instead of $25 billion. Finally, the IPO share price for Paytm was Rs 2150. Many investors who purchased <a href="https://unlistedzone.com/shares/paytm-unlisted-share-price-market-value-today/">Paytm shares</a> in the unlisted market at prices higher than Rs. 2150 suffered significant losses. <h4>Paytm Share price movement in the listed market?</h4> Paytm is the company most negatively hit among those in the tech-driven category. The Paytm stock debuted on the stock exchanges with a 9% reduction to its issue price of Rs. 1955, which was Rs. 2080–2150 per share in the IPO. Paytm shares reached a 52-week low of Rs. 510 in May 2022, wiping down about 75% of the company's market capitalization. The corporation is currently in a recovery period, which has been ascribed to the growth of the loan industry, gains in market share for digital payments, etc. Shares of Paytm are now trading for Rs. 695 per equity share as of the time of writing.
Otis Elevator has announced its annual report for the financial year ended March 31, 2022. As per the report, the net profit of the company has reported a drop of 10%, compared to previous financial year. The company registered 12% growth in total revenue. In FY22, the total revenue of the company was Rs. 1992 crore as against Rs. 1771 crore in the previous financial year. However, the total expenses of the company have also increased to 16% Rs.1793 crore compared to Rs. 1550 crore in the previous financial year. During the financial year ended March 31, 2022, the PBT of the company has reported a drop of 10%. The PBT of the company was Rs. 198 crore as against Rs. 221 crore. The PAT of the company dropped 10%, to Rs. 340 crore compared to Rs. 374 crore in the previous financial year. In FY22, the company registered the drop of 10% in its net profit, to Rs. 146 crore as against Rs. 163 crore in the previous financial year. The Company declared two interim dividends, one on 18th November 2021 of 1350% being 135 per share and a second one on 24th May 2022 of 1000% being Rs 100 per share. All Segments of business grew over last year New equipment revenues grew by16% driven by growth in shipments and field activity Repair and modernization business grew by 23% driven by overall activity pick up post Covid. Maintenance revenues were up 9% mainly driven by portfolio growth. The company adapted its strategy to enhance sales coverage, manage supply chain disruptions and customer needs. The company developed a Business Continuity plan and constantly enhances it to meet the current challenges on supply chain disruption, commodity cost challenges and geo-political situation. In FY22, the company accelerated the digitalization road map with enhancement to digitalization of sales, service, construction and manufacturing activities. The Online Booking gained traction with strong bookings and is now a stable platform for lead generation and order booking. The platform is supported by a sustained Digital Marketing program across key social media platforms. The company strengthened the service sales digitalization using the repair Upgrade application to enable app-based lead generation for repair business. The service sales teams can showcase to customers the various elevator and escalator upgrade packages on their iPhones and generate the lead from the app itself. The company continues to work on the digital initiatives with upcoming enhancements on both manufacturing and installation. The Company continues to be the leader in service portfolio in India with another year of strong growth in portfolio in the year and crossing 100,000 units in its service portfolio. The service delivery has been further strengthened with digitalization. The company added a number of critical features to the Service Transformation, iPhone-based applications to improve service delivery and to sustain the leadership position. Headquartered in Mumbai, OTIS Elevator Company (India) Limited was established in 1953. The company is primarily involved in manufacturing, maintaining and modernization of Elevators, Escalators and moving walkways. It is the subsidiary of United Technologies Corporation.
Philips India Limited has announced its annual report for the financial year ended March 31, 2022. As per the annual report, the total income of the company reported an increase of 14%, to Rs. 5546 crore as against Rs. 4883 crore in the previous financial year. Total expenses of the company have also increased 15%, to Rs. 5312 crore compared to Rs. 4630 crore in FY21. The PBT of the company has reported a massive increase of 44%, to Rs. 364 crore in FY22 as against Rs. 253 crore in the previous financial year. The PAT of the company was Rs. 256 crore, an increase of 45% in FY22 compared to Rs. 176 crore in FY21. The net profit of the company has also increased 51%, to Rs. 265 crore as against Rs. 176 crore in the previous financial year. In FY22, the net worth of the company reported a marginal drop of 5%, to Rs. 2395 crore as against Rs. 2277 crore for the previous financial year. During the year 2021-22, the Health Systems business of the Company delivered strong performance with overall revenue growth of above 60% driven by favorable market growth and customer requirements during the pandemic. In FY22, the company launched two new products - MR 5300 - Helium free 1.5 T MRI and Spectral CT 7500 – Premium CT scan with dual detectors. With these two products, Philips India positioned itself as a leading healthcare company in the industry. The Personal Health business continued its growth journey despite the Covid-19 outbreak and delivered 16.3% growth in a highly competitive market over the previous financial year. Philips Innovation Campus, Bangalore is working on developing products and innovative solutions across the healthcare continuum to improve people’s health. Philips India is a subsidiary of Royal Philips which is a Netherlands-based global health-tech company with a 96.13% shareholding. The company is primarily involved in the manufacturing of Health System Machines (MRIs, CT Scan, Digital X-ray), Personal Care (Trimmer, Hair Dryer), domestic appliances (iron, juicers, food processor), and Innovation center. The company has a manufacturing plant in Pune and a software development center in Bengaluru.
<h4>Basic Details</h4> <p>API holding, the parent company of Pharmeasy, is going to conduct the rights issue to raise funds and strengthen the valuation of the company amid weak market conditions. <br /><br /><strong>1.</strong> As per the letter of offer, the size of the right issue is Rs. 750 crore at the price of Rs. 100 per right issue. <br /><br /><strong>2.</strong> The entitlement ratio is 1:82, which means for 1 CCPS, a shareholder must have 82 equity shares as on the record date 9.09.2022. <br /><br /><strong>3.</strong> The opening date of the rights issue is Sep 21, 2022, and will remain open till Oct 20, 2022 (5 p.m.). Previously the company had plans to raise Rs. 6250 crore money through IPO but due to weak market conditions, the company delayed the IPO. Rights issue is an offer to existing shareholders to purchase the shares of the company. It is one of the prevalent ways for a company to raise capital. In this type of offer, existing shareholders are preferred. If existing shareholders are not willing to purchase then the company goes to the public. <br /><br /><br /><img class="wp-image-24952 aligncenter" src="https://unlistedzone.com/storage/knowledge-logo/Pharmeasy-Right-Issue.jpeg" alt="Pharmeasy Right Issue" width="402" height="402" /></p> <h5>Why Pharmeasy is coming with the Right Issue?</h5> <p>The major objective of the right issue is to increase the firm's valuation, which may help the company achieve a greater valuation at the time of its IPO next year. In the past year, the company's valuation has decreased by roughly half. Currently, the unlisted share price of Pharmeasy is approximately Rs. 40 on the grey market. If it does not increase, it could present complications for the future IPO of the company. Conducting the right issue at Rs. 100 per share will provide the company with a psychological benefit by developing a favourable opinion regarding the company's worth.</p> <h5>Should You Apply in Pharmeasy coming with the Right Issue?</h5> <p>As per our analysis investors should avoid this right issue. Generally, any right issue comes up with a discounted price which is not applied in the case of Pharmeasy. In the grey market, the unlisted shares price of Pharmeasy are being traded at around Rs. 40 while the right issue is priced at Rs. 100 per equity share which is far cheaper. So why one would invest at such a higher price? Pharmeasy is a startup incorporated in 2015. It is India's fastest-growing online pharmacy which aims to deliver everything related to healthcare along with diagnostic services and doctor-on-call services. The company was founded by Dharmil Seth and Dhawal Shah. The company has achieved many milestones. It has acquired one of its rivals Medlife, It has further acquired cloud-based hospital supply chain management startup Aknamed and one listed company Thyrocare and many more. The company is the largest online pharmacy in India serving 1000+ cities.</p>
<div class="tatsu-module tatsu-inline-text clearfix tatsu-SyGuBuH2Hh "> <div class="tatsu-inline-text-inner "> <p>“Five years back, it was mostly from HNIs but now, retail investors are also participating” said Umesh Paliwal, Co-Founder of UnlistedZone</p> </div> </div> <div class="tatsu-animated-link tatsu-animated-link-style4 tatsu-BJV_HOHhB2 tatsu-module tatsu-animated-link-align-none "><a class="tatsu-animated-link-inner " href="https://www.dsij.in/dsijarticledetail/how-to-buy-unlisted-shares-know-the-nitty-gritty-involved-in-them-26588" target="_blank" rel="noopener" aria-label="Read Full Article Here"><span class="tatsu-animated-link-text">Read Full Article Here</span></a></div>
<a href="https://unlistedzone.com/storage/knowledge-logo/API-Rights-Draft-FAQs-Final.pdf">Rights Issue of Compulsorily Convertible Preference Shares By API Holdings Limited</a>
Capgemini Technology Services India Limited has announced its annual results. In the financial year ended March 31, 2022, the company reported an increase of 28% in its gross revenue to Rs. 23065 crore as against Rs. 18045 crore in FY21. The total expenses of the company have also increased 28% to Rs. 19884 crore as against Rs. 15433 crore in the previous financial year. The PBT of the company has increased by 22%, to Rs. 3180 crore in FY22 as against Rs. 2612 crore in the previous financial year. The net profit of the company has increased massively by 37% to Rs. 2307 crore as against Rs. 1688 crore in the previous financial year. The EBITDA has increased 17%, to Rs. 4131 crore as against Rs. 3543 crore in the previous financial year. The company has not declared any dividends for the financial year 2022. The company has delivered a remarkable performance in terms of net profit, cash generation, and growth. The company was able to maintain solid momentum across all the business lines. Digital and cloud services activities contributed a significant role in all the activities of the company. The company also benefited from the acquisition of Altran. The company continued to grow organically this year as well, despite the COVID-19 challenges. Capgemini Technology Services India Limited is a public limited company domiciled in India. The company is primarily engaged in providing information technology solutions, which include software product development services, software consulting services, BPO and outsourcing solutions to large and medium sized organizations. The company has a center almost in all major IT cities of the country such as Bengaluru, Hyderabad, Pune, Noida, Mumbai, Gurugram, Chennai, Kolkata etc
Indicative prices, company research and your enquiries — in your pocket. Get price notes on the names you follow and reach our team from anywhere.
